How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
A Methamphetamine Test Kit (Colloidal Gold) Market
- By Product Type: Single Panel Methamphetamine Test Kit, Multi-Panel Drug Test Kit including Methamphetamine, Disposable Methamphetamine Test Kit, Reusable Methamphetamine Test Kit
- By Sample Type: Urine Test Kit, Saliva Test Kit, Blood Test Kit, Sweat Test Kit
- By End User: Clinical Laboratories, Forensic Laboratories, Rehabilitation Centers, Workplace Testing, Law Enforcement Agencies
- By Distribution Channel: Direct Sales, Online Retail, Pharmacies and Drug Stores, Medical Supply Distributors
- By Test Format: Lateral Flow Immunoassay, Colloidal Gold Immunochromatographic Assay, Enzyme-Linked Immunosorbent Assay (ELISA)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Single Panel Methamphetamine Test Kit leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the A Methamphetamine Test Kit (Colloidal Gold) Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Sample Type 4
End User 5
Distribution Channel 4
Test Format 3
Companies profiled
Abbott Laboratories
Thermo Fisher Scientific
Siemens Healthineers
Alere Inc. (now part of Abbott)
OraSure Technologies
Ningbo David Medical Device Co. Ltd.
Hangzhou Testsea Biotechnology Co. Ltd.
Beijing Strong Biotechnologies Inc.
Wondfo Biotech Co. Ltd.
ACON Laboratories Inc.
Medi-Test Diagnostics
Nal Von Minden GmbH
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Alere Inc. (now part of Abbott)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →OraSure Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ningbo David Medical Device Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hangzhou Testsea Biotechnology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Beijing Strong Biotechnologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Wondfo Biotech Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ACON Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Medi-Test Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Nal Von Minden GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jiangsu Truking Technology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Biosite Inc. (now part of Alere)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Roche Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,448M by 2033 · 4.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Single Panel Methamphetamine Test Kit48.0
- Multi-Panel Drug Test Kit including Methamphetamine20.5
- Disposable Methamphetamine Test Kit14.8
- Reusable Methamphetamine Test Kit16.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$330.5M → $472.8M · 4.6%
Europe$230.4M → $335.9M · 4.8%
Asia Pacific$210.3M → $315.3M · 5.2%
Latin America$130.2M → $191.3M · 4.9%
Middle East and Africa$100.2M → $145.4M · 4.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.682026
4.692027
4.682028
4.712029
4.722030
4.742031
4.742032
4.762033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories18.8
- Thermo Fisher Scientific11.4
- Siemens Healthineers9.2
- Alere Inc. (now part of Abbott)10.6
- OraSure Technologies13.6
- Ningbo David Medical Device Co. Ltd.8.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.1%
Sample Type27.0%
End User25.0%
Distribution Channel10.4%
Test Format17.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.4
- Europe23.0
- Asia Pacific21.6
- Latin America13.1
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 83 | 79 | 98 | 95 | 77 | 97 | 88 |
| Thermo Fisher Scientific | 84 | 77 | 87 | 77 | 80 | 86 | 82 |
| Siemens Healthineers | 87 | 64 | 86 | 82 | 70 | 66 | 76 |
| Alere Inc. (now part of Abbott) | 71 | 74 | 77 | 79 | 71 | 68 | 73 |
| OraSure Technologies | 64 | 62 | 57 | 60 | 63 | 75 | 64 |
| Ningbo David Medical Device Co. Ltd. | 53 | 70 | 69 | 68 | 70 | 67 | 66 |
| Hangzhou Testsea Biotechnology Co. Ltd. | 40 | 63 | 58 | 61 | 56 | 62 | 57 |
| Beijing Strong Biotechnologies Inc. | 51 | 55 | 55 | 51 | 42 | 47 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- Thermo Fisher Scientific
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Thermo Fisher Scientific | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Siemens Healthineers | ✓ | − | ✓ | ◐ | ✓ | ✓ |
| Alere Inc. (now part of Abbott) | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| OraSure Technologies | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Ningbo David Medical Device Co. Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Hangzhou Testsea Biotechnology Co. Ltd. | − | − | ◐ | ◐ | ◐ | − |
| Beijing Strong Biotechnologies Inc. | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Abbott Laboratories88
2Thermo Fisher Scientific82
3Siemens Healthineers76
4Alere Inc. (now part of Abbott)73
5Ningbo David Medical Device Co. Ltd.66
6OraSure Technologies64
7Hangzhou Testsea Biotechnology Co. Ltd.57
8Beijing Strong Biotechnologies Inc.50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Abbott LaboratoriesThermo Fisher Scientific
Challenger2
Strong scale, closing on the leaders.
Siemens HealthineersAlere Inc. (now part of Abbott)
Contender3
Focused players with pockets of strength.
OraSure TechnologiesNingbo David Medical Device Co. Ltd.Hangzhou Testsea Biotechnology Co. Ltd.
Niche1
Specialists in a single segment or region.
Beijing Strong Biotechnologies Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across A Methamphetamine Test Kit (Colloidal Gold) Market — a $373M beachhead inside a $5.49B market.
Beachhead (SOM)$373Mobtainable near-term
Serviceable (SAM)$2.00Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Single Panel Methamphetamine Test Kit
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Multi-Panel Drug Test Kit including Methamphetamine
Strong fit — clear ROI and a fast path to value.
End user65 fit
Disposable Methamphetamine Test Kit
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Sample Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve20%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win A Methamphetamine Test Kit (Colloidal Gold) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified21%
Evaluation12%
Closed-won7%
$14.4KCAC
$77KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
A Methamphetamine Test Kit (Colloidal Gold) Market is a durable-growth opportunity — $6.65B by 2033, compounding at 9.1%.
TAM · 2025$3.31Btoday
TAM · 2033$6.65Bforecast
CAGR9.1%2027–2033
Cumulative$43.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.65BTotal addressable market
SAM$2.70BServiceable available market
SOM$517MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.65BLarge & growingTAM by 2033 at 9.1% CAGR
$2.70BServiceable nowreachable with today’s model
$517MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.19BBear5.9% CAGR
$6.65BBase9.1% CAGR
$8.51BBull12.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Sample Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
A Methamphetamine Test Kit (Colloidal Gold) Market — a $5.73B market by 2033. Plan: grow share from 7.7% to 12.0%.
Market size · 2033$5.73Btotal addressable
Market CAGR6.6%2027–2033
Target share12.0%from 7.7% today
Revenue ambition$688Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 12.0% | On track |
| Revenue | $413M | $688M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 29.8% | 39.2% | On track |
| Customer retention | 89.2% | 95.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Sample Type capability
A defensible second engine — invest in Sample Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Sample Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $102M capacity & capability investment
- Greenlight bolt-on M&A in Sample Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the A Methamphetamine Test Kit (Colloidal Gold) Market conversation — a $5.05B market you can size, segment and defend in minutes.
Market size · 2033$5.05Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers1,376+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 2 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Abbott LaboratoriesThermo Fisher ScientificSiemens HealthineersAlere Inc. (now part of Abbott)OraSure TechnologiesNingbo David Medical Device Co. Ltd.Hangzhou Testsea Biotechnology Co. Ltd.Beijing Strong Biotechnologies Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your A Methamphetamine Test Kit (Colloidal Gold) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
A Methamphetamine Test Kit (Colloidal Gold) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →A or B Testing Software Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportA or B Testing Tools Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportA Pavement Grooving Machine Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportA Photosensitive Coating Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportA Raw Powder Market
Market size, share, segmentation and regional forecast.
$812M market · 2025 base year
View reportA Test Of Benproperine Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportA Transistor Radio Frequency Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportA Trowel Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportA Type Papermaking Repellents Market
Market size, share, segmentation and regional forecast.
$764M market · 2025 base year
View reportA/C O-Ring Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportA/C Receiver Drier Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportA1C Test Kit Market
Market size, share, segmentation and regional forecast.
$668M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.